The leader of the Ukrainian pharmaceutical market*, Farmak participated in one of most prestigious global events of the pharmaceutical industry – CPHI 2024 on October 8-10, 2024, in Milan, Italy. This year, the exhibition united over 2400 exhibitors and 62 thousand visitors of over 166 countries of the world, as well as over 150 expert speakers who discussed the key innovations and trends of the pharmaceutical industry.
At CPHI Milan 2024, Farmak presented its therapeutic solutions and a strategic portfolio, which comprises complex generics, contrast agents for MRI and CT, anaesthesiology agents, intensive care drugs, as well as OTC medicines.
CPHI is an important event for the global pharmaceutical community, which has become a platform for networking for new partnerships, experience sharing, and exploring of modern developments in the industry.
According to Corporate Strategy Farmak 2.0: “From local to global success”, the Company has been actively expanding its international presence and continues expansion in the new markets. By late September, A&S Pharma Holdings Ltd, a British group of companies, was acquired. Earlier, the presence in Poland, Czechia and Slovakia was expanded by acquisition of marketing companies. In late 2024, a new manufacturing site in Barcelona, Spain, will be opened.
*Based on sales of medicinal products expressed in monetary terms, according to Proxima Research in 2023
